Doxorubicin Hydrochloride (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Doxorubicin Hydrochloride drug offered from Fresenius Kabi USA, LLC. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | DOXORUBICIN HYDROCHLORIDE |
SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-06-14 |
END MARKETING DATE: | 0000-00-00 |
Doxorubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Doxorubicin Hydrochloride from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2000-06-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-101_f48b1ac2-923f-4825-9c44-02df9253cf96 |
PRODUCT NDC: | 63323-101 |
APPLICATION NUMBER: | ANDA063277 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: